Chase Knickerbocker
Stock Analyst at Craig-Hallum
(1.28)
# 1819
Out of 5,368 analysts
41
Total ratings
52.38%
Success rate
12.64%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
PHAT Phathom Pharmaceutic... | Maintains: Strong Buy | 12 17 | 10.65 | 59.62% | 2 | Jun 9, 2025 | |
FENC Fennec Pharmaceutica... | Maintains: Strong Buy | 12 13 | 7.96 | 63.32% | 5 | May 14, 2025 | |
ETON Eton Pharmaceuticals | Maintains: Strong Buy | 26 28 | 14.3 | 95.8% | 6 | May 14, 2025 | |
XERS Xeris Biopharma Hold... | Maintains: Strong Buy | 5 7 | 4.36 | 49.08% | 1 | Mar 7, 2025 | |
MDWD MediWound | Initiates Coverage On: Buy | 39 | 20.35 | 91.65% | 1 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 8 | 0.62 | 1190.32% | 4 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 18 21 | 15.34 | 36.9% | 2 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 5 6 | 3.23 | 85.76% | 2 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 16 12 | 3.96 | 203.03% | 2 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 3.43 | 191.55% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 20 16 | 13.89 | 15.19% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 45 65 | 30.36 | 114.1% | 3 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 6 8 | n/a | n/a | 2 | Sep 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14 12 | 6.04 | 98.68% | 2 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 7.7 | 29.87% | 1 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 22 23 | 9.58 | 140.08% | 2 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 1 2 | 0.63 | 90.48% | 2 | Jul 11, 2023 |